MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42 | -44.7% | 12,869 | -30.2% | 0.01% | -28.6% |
| Q1 2023 | $76 | -47.2% | 18,437 | -24.8% | 0.01% | -50.0% |
| Q4 2022 | $144 | -99.9% | 24,533 | -22.6% | 0.01% | -33.3% |
| Q3 2022 | $214,000 | +122.9% | 31,698 | +52.1% | 0.02% | +90.9% |
| Q2 2022 | $96,000 | +41.2% | 20,836 | +22.4% | 0.01% | +37.5% |
| Q1 2022 | $68,000 | -66.7% | 17,027 | -48.2% | 0.01% | -65.2% |
| Q4 2021 | $204,000 | -24.2% | 32,871 | +65.8% | 0.02% | -14.8% |
| Q2 2021 | $269,000 | +195.6% | 19,821 | +27.7% | 0.03% | +50.0% |
| Q1 2020 | $91,000 | +378.9% | 15,524 | +31.9% | 0.02% | +500.0% |
| Q3 2019 | $19,000 | – | 11,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |